Lay Teng Tan

Dr. Lay Teng Tan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
COConor John O'Donovan
Conor John O'Donovan
LTLay Teng Tan
Lay Teng Tan
MAMohd Azri bin Zainal Abidin
Mohd Azri bin Zainal Abidin
MRMarion R. Roderick
Marion R. Roderick
AGAlexandros Grammatikos
Alexandros Grammatikos
JBJolanta Bernatoniene
Jolanta Bernatoniene
Chronic granulomatous disease (CGD) is a group of rare primary inborn errors of immunity characterised by a defect in the phagocyte respiratory burst, which leads to severe and life-threatening infective and inflammatory complications. Despite recent advances in our understanding of the genetic and molecular pathophysiology of X-linked and autosomal recessive CGD, and growth in the availability of functional and genetic testing, there remain significant barriers to early and accurate diagnosis. In the current review, we provide an up-to-date summary of CGD pathophysiology, underpinning current methods of diagnostic testing for CGD and closely related disorders. We present an overview of the benefits of early diagnosis and when to suspect and test for CGD. We discuss current and historical methods for functional testing of NADPH oxidase activity, as well as assays for measuring protein expression of NADPH oxidase subunits. Lastly, we focus on genetic and genomic methods employed to diagnose CGD, including gene-targeted panels, comprehensive genomic testing and ancillary methods. Throughout, we highlight general limitations of testing, and caveats specific to interpretation of results in the context of CGD and related disorders, and provide an outlook for newborn screening and the future.

1 October 2020 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
LTLay Teng Tan
Lay Teng Tan
ANAnna Marie Nathan
Anna Marie Nathan
SJSubhashini Jayanath
Subhashini Jayanath
KEKah Peng Eg
Kah Peng Eg
STSurendran Thavagnanam
Surendran Thavagnanam
JBJessie Anne de Bruyne
Jessie Anne de Bruyne

18 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
COConor John O'Donovan
Conor John O'Donovan
LTLay Teng Tan
Lay Teng Tan
MAMohd Azri bin Zainal Abidin
Mohd Azri bin Zainal Abidin
MRMarion Ruth Roderick
Marion Ruth Roderick
AGAlexandros Grammatikos
Alexandros Grammatikos
JBJolanta Bernatoniene
Jolanta Bernatoniene
Chronic granulomatous disease (CGD) is a group of rare primary inborn errors of immunity characterised by a defect in the phagocyte respiratory burst, which leads to severe and life-threatening infective and inflammatory complications. Despite recent advances in our understanding of the genetic and molecular pathophysiology of X-linked and autosomal recessive CGD, and growth in the availability of functional and genetic testing, there remain significant barriers to early and accurate diagnosis. In the current review, we provide an up-to-date summary of CGD pathophysiology, which underpins methods of diagnostic testing for CGD and closely related disorders. We present an overview of the benefits of early diagnosis and when to suspect and test for CGD. We discuss current and historical methods for functional testing of NADPH oxidase activity, as well as assays for measuring protein expression of NADPH oxidase subunits. Lastly, we focus on genetic and genomic methods employed to diagnose CGD, including gene-targeted panels, comprehensive genomic testing and ancillary methods. Throughout, we highlight general limitations of testing, and caveats specific to interpretation of results in the context of CGD and related disorders, and provide an outlook for newborn screening and the future.